2个枪支暴力数据集的概率记录链接
Iris Horng1, Qishuo Yin2, William Chan3
1Department of Statistics and Data Science, University of Pennsylvania, Philadelphia, PA, USA.
Public health reports (Washington, D.C. : 1974)
|July 4, 2025
概括
从枪支暴力档案 (GVA) 和国家暴力死亡报告系统 (NVDRS) 合并枪支暴力数据是可行的. 这种联系实现了90.1%的准确率,提高了公共卫生策略的数据实用性.
科学领域:
- 公共卫生 公共卫生
- 数据科学数据科学数据科学
- 犯罪学 犯罪学
背景情况:
- 枪支暴力在美国是一个关键的公共卫生问题.
- 像GVA和NVDRS这样的现有数据集提供了关于枪支暴力的补充数据.
- 整合这些数据集可以改善理解和干预策略.
研究的目的:
- 开发和评估一种将来自GVA和NVDRS的枪支暴力数据合并的方法.
- 提高枪支暴力数据集的分析实用性,用于公共卫生研究.
- 为旨在减少美国枪支暴力率的战略提供信息.
主要方法:
- 使用概率记录链接将GVA和NVDRS记录合并.
- 在链接之前进行了数据预处理.
- 使用手动评估来评估链接的准确性和敏感性,重点是错误匹配率.
主要成果:
- 在GVA和NVDRS数据集之间共发现了27,420个匹配.
- 手动评估942个匹配的记录 (由于GVA数据的限制) 的准确率为90.1%.
- 开发的框架在将两组数据集之间的枪支暴力事件联系起来方面表现出了很高的准确性.
结论:
- 来自不同来源的枪支暴力数据的电子链接是一个可行的方法.
- 合并GVA和NVDRS数据显著增加了信息的整体实用性.
- 这种综合数据方法可以支持更有效的分析和干预措施,以减少枪支暴力.
相关概念视频
Wilcoxon Signed-Ranks Test for Matched Pairs
225
The Wilcoxon signed-rank test for matched pairs evaluates the null hypothesis by combining the ranks of differences with their signs. It essentially tests whether the median of the differences in a population of matched pairs is zero. Since the test incorporates more information than the sign test, it generally yields more trustable conclusions. This test also does not require the data to follow a normal distribution, but two conditions must be met for it to be applicable: (1) the data must...
225
Comparing the Survival Analysis of Two or More Groups
297
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
297
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Correlation of Experimental Data
272
Dimensional analysis simplifies complex physical problems and guides experimental investigations, but it does not provide complete solutions. It identifies the dimensionless groups that influence a phenomenon, but experimental data is needed to establish the specific relationships and validate theoretical predictions.
For example, a spherical particle moving through a viscous fluid experiences drag. Dimensional analysis shows that the drag force depends on the particle's diameter, velocity,...
For example, a spherical particle moving through a viscous fluid experiences drag. Dimensional analysis shows that the drag force depends on the particle's diameter, velocity,...
272
Statistical Methods for Analyzing Epidemiological Data
544
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
544
Hazard Ratio
257
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
257


